Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
KadeFlora Milchsäureovula vaginal pH and tolerability study
DRKS00036161Phase 3Completed
- Sponsor
- DR. KADE Health Care
- Start
- Feb 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of lactic acid in Vaginal dysbiosis, sponsored by DR. KADE Health Care. Primary endpoints: Local tolerability of KadeFlora Milchsäureovula and Change in vaginal pH. Started Feb 2025; status: completed.
02
Drugs
lactic acid
03
Conditions
Vaginal dysbiosis
Beyond the preview
Go deeper on DRKS00036161.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on DRKS00036161.